HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yongmin Zhang Selected Research

ergosta-4,6,8(14),22-tetraen-3-one

12/2011Ergosta-4,6,8(14),22-tetraen-3-one isolated from Polyporus umbellatus prevents early renal injury in aristolochic acid-induced nephropathy rats.
4/2011Ergosta-4,6,8(14),22-tetraen-3-one induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.
10/2010Cytotoxic steroids from Polyporus umbellatus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yongmin Zhang Research Topics

Disease

24Neoplasms (Cancer)
08/2022 - 10/2010
9Human Influenza (Influenza)
02/2022 - 02/2016
7Infections
02/2022 - 07/2017
5Colitis
07/2016 - 10/2011
4Ulcerative Colitis
07/2016 - 10/2011
4Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
07/2016 - 10/2011
3Necrosis
02/2018 - 07/2016
3Body Weight (Weight, Body)
07/2016 - 12/2011
2Neoplasm Metastasis (Metastasis)
01/2022 - 10/2008
2Melanoma (Melanoma, Malignant)
11/2021 - 01/2019
2Adenocarcinoma
06/2021 - 12/2020
2Colonic Neoplasms (Colon Cancer)
06/2021 - 12/2020
2Tuberculosis (Tuberculoses)
10/2020 - 01/2020
2Virus Diseases (Viral Diseases)
01/2020 - 07/2017
2Insulin Resistance
09/2019 - 10/2018
2Non-alcoholic Fatty Liver Disease
06/2019 - 10/2018
2Stomach Ulcer (Gastric Ulcer)
02/2018 - 11/2017
2Chronic Kidney Failure (Chronic Renal Failure)
02/2012 - 12/2011
1Neurodegenerative Diseases (Neurodegenerative Disease)
02/2022
1Mixed Connective Tissue Disease (MCTD)
02/2022
1Thrombosis (Thrombus)
01/2022
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2022
1Tinnitus
12/2021
1Hearing Loss (Hearing Impairment)
12/2021
1Breast Neoplasms (Breast Cancer)
11/2021
1Triple Negative Breast Neoplasms
11/2021
1Mucopolysaccharidosis III (Sanfilippo Syndrome)
08/2021
1Rare Diseases (Rare Disease)
08/2021
1Liver Neoplasms (Liver Cancer)
08/2021
1Stomach Neoplasms (Stomach Cancer)
06/2021
1Prostatic Neoplasms (Prostate Cancer)
06/2021
1Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2020
1Carcinoma (Carcinomatosis)
12/2020

Drug/Important Bio-Agent (IBA)

7Pharmaceutical PreparationsIBA
08/2022 - 01/2013
6Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2014
5VaccinesIBA
08/2022 - 01/2020
5AntigensIBA
08/2022 - 01/2019
5EnzymesIBA
02/2022 - 02/2008
5CyclodextrinsIBA
02/2022 - 02/2016
5Biological ProductsIBA
11/2021 - 10/2011
5G(M3) GangliosideIBA
11/2021 - 02/2018
4Antineoplastic Agents (Antineoplastics)IBA
11/2021 - 03/2019
4TriterpenesIBA
11/2021 - 02/2016
4Hemagglutinins (Hemagglutinin)IBA
01/2020 - 03/2016
4Interleukin-6 (Interleukin 6)IBA
10/2018 - 10/2011
4Peroxidase (Myeloperoxidase)IBA
02/2018 - 01/2013
4Sulfasalazine (Azulfidine)FDA LinkGeneric
07/2016 - 10/2011
3Glucose (Dextrose)FDA LinkGeneric
08/2022 - 10/2018
3SugarsIBA
02/2022 - 03/2014
3Antiviral Agents (Antivirals)IBA
02/2022 - 07/2017
3GlycosphingolipidsIBA
01/2021 - 03/2014
3Polysaccharides (Glycans)IBA
10/2020 - 04/2016
3CarbohydratesIBA
03/2020 - 01/2019
3CytokinesIBA
06/2019 - 11/2011
3Ethanol (Ethyl Alcohol)IBA
10/2018 - 01/2013
3Sulfonic AcidsIBA
01/2013 - 10/2011
3ergosta-4,6,8(14),22-tetraen-3-oneIBA
12/2011 - 10/2010
2GlycopeptidesIBA
08/2022 - 01/2018
2LigandsIBA
02/2022 - 07/2017
2Betulinic AcidIBA
02/2022 - 03/2016
2LipidsIBA
01/2022 - 10/2018
2Therapeutic UsesIBA
12/2021 - 10/2006
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
06/2021 - 12/2020
2Organoselenium CompoundsIBA
06/2021 - 12/2020
2Liposomes (Liposome)IBA
12/2020 - 01/2017
2GlycoconjugatesIBA
10/2020 - 01/2018
2GlucosidasesIBA
09/2019 - 01/2008
2FructoseIBA
06/2019 - 10/2018
2GlycolipidsIBA
01/2019 - 01/2018
2gentiopicrosideIBA
02/2018 - 04/2017
2N-Acetylneuraminic Acid (Sialic Acid)IBA
07/2017 - 03/2014
2AcidsIBA
07/2016 - 03/2016
2InterleukinsIBA
07/2016 - 07/2016
2InterferonsIBA
07/2016 - 07/2016
1triptolideIBA
08/2022
1FluorineIBA
08/2022
1Amino AcidsFDA Link
02/2022
1Human immunodeficiency virus 1 p16 proteaseIBA
02/2022
11-phenyl-3,3-dimethyltriazene (PDT)IBA
02/2022
1Peptides (Polypeptides)IBA
02/2022
1FullerenesIBA
02/2022
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2022
1AnticoagulantsIBA
01/2022
1Sterol Regulatory Element Binding Protein 1IBA
01/2022
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
01/2022
1Glycyrrhetinic Acid (Po 12)IBA
01/2022
1Phenobarbital (Luminal)FDA Link
11/2021
1Adenosine Triphosphate (ATP)IBA
11/2021
1PlatinumIBA
11/2021
1lyso-G(M3) gangliosideIBA
11/2021
1Heparitin Sulfate (Heparan Sulfate)IBA
08/2021
1Glycoside Hydrolases (Endoglycosidases)IBA
08/2021
1GlycosidesIBA
08/2021
1alpha-N-acetyl-D-glucosaminidase (alpha-N-acetylglucosaminidase)IBA
08/2021
1Acetylglucosaminidase (NAGase)IBA
08/2021
1SaponinsIBA
08/2021
1Topotecan (Hycamtin)FDA LinkGeneric
12/2020

Therapy/Procedure

6Therapeutics
12/2021 - 01/2018
2Oral Administration
02/2018 - 11/2017
1Photochemotherapy (Photodynamic Therapy)
02/2022